1. Medtech Insight
  2. >>Archive

FDA Panel Narrowly Endorses Mela Sciences’ Melanoma Detection System

An FDA advisory panel Nov. 18 narrowly endorsed Mela Sciences’ MelaFind melanoma detection system, voting 8-7, with one abstention, that the benefits outweigh any risks.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Archive

More from Medtech Insight